The specific legal question is whether the Public Health Agency of Sweden’s decision not to take special measures, despite the ECDC’s risk assessment and indications of local Swedish transmission chains of ceftriaxone-resistant gonorrhoea, can be supported by a sufficiently documented risk and proportionality assessment.
The material provided contains no specific statutory provision or case law, so the analysis is based solely on a general principle of administrative law. A Swedish authority dealing with communicable-disease risks must have an objective evidential basis for its assessment and choose measures that are justified, appropriate and proportionate in relation to the risk. The legally relevant issue here is therefore not merely the number of cases, but the risk profile: nine cases last year, four so far this year, a previous maximum of three per year, suspected domestic transmission, and resistance to the first-line treatment ceftriaxone.
The stronger argument now is that the authority’s margin of discretion must be assessed against the change in the nature of the risk, not against the fact that the absolute numbers remain low. For lawyers and journalists, the practical point of scrutiny is whether the Public Health Agency of Sweden can demonstrate why the special surveillance programme is sufficient when the ECDC is simultaneously urging EU countries to strengthen resistance surveillance and when treatment failures may increase. The concrete risk is that a passive response will appear inadequately reasoned if there is no documented analysis of local transmission chains, treatment failure and alternative measures.